recall
saveAurobindo Pharma USA Inc recall (Cls II)
December 25, 2024updated 5mo ago
community read0 votes
Nebivolol Tablets, 2.5. mg, 30-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520. NDC: 59651-137-30 — Reason: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso Nebivolol above acceptable intake (AI) limit. — Status: Ongoing
view source ↗Data sources
last refreshed 31m ago
Found something off?
same company · ±60 days · 5
- recallAurobindo Pharma USA Inc recall (Cls II)Dec 11, 2024
- recallAurobindo Pharma USA Inc recall (Cls II)Dec 11, 2024
- recallAurobindo Pharma USA Inc recall (Cls II)Dec 11, 2024
- approvalDICLOFENAC SODIUM: DICLOFENAC SODIUM — FDA approvalNov 21, 2024
- recallThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recall (Cls II)Feb 12, 2025
🐶 often sniffed alongside
top 8- tagApproval118 co-mentions · 59 sources
- companyAurobindo Pharma Ltd81 co-mentions · 69 sources
- tagSmall Molecule59 co-mentions · 59 sources
- drugBUPROPION HYDROCHLORIDE26 co-mentions · 26 sources
- drugbupropion hydrochloride MR26 co-mentions · 26 sources
- drugbupropion hydrochloride ER26 co-mentions · 26 sources
- drugbupropion26 co-mentions · 26 sources
- drugAUVELITY26 co-mentions · 26 sources
comments(0)
5-min edit window · permanent after that